In 2,367 women treated for breast cancer at Syria's principal cancer hospital between 2019 and 2022, fewer than 5% were found by screening mammography, 8% were diagnosed at stage 0 or I and 19% had metastatic disease.
Published as "Breast cancer quality of care in Syria: screening, diagnosis, and staging". A retrospective review of 4,500 paper charts of breast cancer patients treated at Al-Bairouni University Hospital in Harasta from January 2019 to May 2022; 2,367 remained after excluding neoadjuvant treatment and incomplete charts. The authors describe the hospital as the principal cancer centre in Syria, hosting patients from all over the country.
Breast cancer in Syria is mostly found late and often diagnosed by surgery rather than a needle biopsy, which points to screening and diagnostic services as the first gaps to close.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/